Valeant Pharmaceuticals International (VRX) Agrees to Acquire Medicis Pharmaceutical Corporation (MRX)
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) and Medicis Pharmaceutical Corporation (NYSE:MRX) announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Medicis for $44.00...